Seoul National University Bundang Hospital (SNUBH)
Glioblastoma treatment cost in the Republic of Korea is primarily determined by the tumor stage and chosen surgical approach. A brain MRI with contrast typically costs $700 to $1,200, while specialized treatment like Gamma Knife runs from $13,500 to $19,200. Patients often save between 30-50% compared to the United States. High-end neurosurgical care is concentrated in Seoul.
Typical Glioblastoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex glioblastoma cases, multidisciplinary care at JCI-accredited centers in Seoul offers the best value. Severance Hospital provides integrated care with 2,000 doctors at a JCI-certified facility. Patients seeking advanced digital safety should consider Seoul National University Bundang Hospital (SNUBH). It utilizes the BESTcare system for medical safety. Korea University Anam Hospital is ideal for those requiring specialized robotic oncology surgery.
| Republic of Korea | Turkey | Austria | |
| Gamma Knife | from $13,500 | from $6,300 | from $32,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Resection of glioblastoma | - | from $14,400 | - |
| Halcyon | - | from $5,400 | - |
| Actinium-225 Therapy | - | from $22,955 | from $55,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Glioblastoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glioblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glioblastoma treatment journey.
Dr. Do Hyun Nam is renowned for endoscopic brain surgeries and tumor removal at Samsung Medical Center – one of South Korea's top hospitals.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Dr. Kim Jin is a colorectal surgeon at Korea University Anam Hospital in Seoul. He is the Vice President of the Korean Association of Robotic Surgeons. Dr. Kim represents South Korea on the board of the Asia Pacific Endo-Lap Surgery Group. He performs surgical demonstrations for medical faculties in Hong Kong and Singapore.
Glioblastoma surgery in Korea is exceptionally safe for international patients. Facilities maintain a 95% efficacy rate for brain tumor removal procedures. Most top-tier centers hold JCI or KOIHA accreditation. These hospitals utilize fluorescence-guided resection to maximize tumor removal while protecting healthy tissue.
Bookimed Expert Insight: Korea offers a unique safety advantage through its massive patient volumes. Asan Medical Center serves over 11,000 outpatients daily. This high frequency allows surgeons to refine techniques far faster than in lower-volume European centers. When choosing a clinic, prioritize those using 100% digital data systems like SNUH. Electronic health records significantly reduce medication errors for international patients whose records may be complex.
Patient Consensus: Patients emphasize that while Korean technology and surgical equipment are world-class, arranging video consultations before traveling is vital. They also suggest budgeting extra for translation support to ensure clear communication during recovery.
You may receive both awake mapping and fluorescence-guided resection during glioblastoma surgery in South Korea. Glioblastoma is a high-grade tumor often requiring aggressive removal. Surgeons use fluorescence for visualization and mapping to protect functions like speech. These techniques are standard at JCI-accredited centers in Seoul.
Bookimed Expert Insight: Seoul National University Hospital handles over 10,000 patients daily and is a leading choice for glioblastoma. High patient volumes indicate deep expertise in complex neurosurgery. Clinics like Asan Medical Center also maintain Joint Commission International (JCI) accreditation. This ensures they follow the strictest global safety protocols for brain mapping procedures.
Patient Consensus: Patients note that awake surgery sounds scary but feels worth it for a higher resection rate. They recommend asking for functional magnetic resonance imaging (fMRI) beforehand to see if mapping is truly necessary.
Residual tumor cells after glioblastoma surgery in South Korea are managed through aggressive adjuvant therapies. Surgeons often leave microscopic cells to protect healthy brain tissue. Standard protocols include specialized MRI scans within 48 hours. These scans quantify remaining tumor volume to guide immediate chemotherapy or radiation.
Bookimed Expert Insight: Patient data shows Korean hospitals like Seoul National University Hospital achieve high cancer treatment statistics by digitizing surgical workflows. Tracking residual volume within 48 hours is vital. This precision allows doctors to adjust doses for patients with methylated tumors. Such detail often extends survival beyond the typical 15-month mark.
Patient Consensus: Patients emphasize asking for MGMT testing immediately. They note that even with 10% residual tumor, combined therapies and proton centers help maintain a good quality of life.
Glioblastoma treatment in South Korea typically requires an inpatient hospital stay of 7 to 14 days following surgical resection. Initial recovery takes 2 to 4 weeks before starting adjuvant radiation or chemotherapy. Specialized centers manage complex cases with intensive monitoring to ensure neurological stability.
Bookimed Expert Insight: Clinical data shows Seoul National University Bundang Hospital utilizes the BESTcare digital system to prevent errors. This automation shortens recovery by streamlining medication and scan schedules for oncology patients. Choosing a fully digital hospital reduces the risk of post-surgical delays significantly.
Patient Consensus: Patients note the recovery process feels faster due to the highly efficient coordination of nursing staff. Many emphasize that having clear post-surgical instructions helped them transition to home care with lower stress levels.
Preparation for glioblastoma surgery in South Korea requires high-resolution brain MRI scans with contrast. You must provide original DICOM files from the past 1–3 months. Include full pathology reports with molecular markers like IDH and MGMT. Bring these on two backup USB drives. Hospitals often redo tests older than 14 days.
Bookimed Expert Insight: While major centers like Asan Medical Center and Severance Hospital use advanced digital systems, they strictly prioritize high-resolution DICOM data. Our data shows that top-tier Korean facilities, including Seoul National University Hospital, treat thousands of oncology patients daily. Because of this high volume, surgeons usually reject emailed JPGs or simple summaries. Having your records translated into Korean and stored on two separate USB drives prevents delays in these fast-paced environments.
Patient Consensus: Patients note that bringing digital pathology files is vital because simple paper summaries are often rejected. It is helpful to bring a printed medication list to show how your symptoms have progressed.
You can receive both proton-beam and carbon-ion therapy in South Korea. The Yonsei Heavy Ion Therapy Center at Severance Hospital offers carbon-ion treatment. Samsung Medical Center and the National Cancer Center provide proton-beam therapy using high-precision pencil-beam scanning technology for glioblastoma and other brain tumors.
Bookimed Expert Insight: While proton therapy is established, carbon-ion therapy at Severance Hospital is a rare resource. Our data shows Severance manages 4,000,000 patients annually. This high volume suggests their multidisciplinary teams are exceptionally efficient at screening complex glioblastoma cases for these specialized radiation protocols.
Patient Consensus: Patients value the high-tech digital systems at hospitals like SNUH and Severance. They often mention that having international centers helps manage the complex documentation needed for advanced radiation oncology.
The primary neuro-oncology clusters for international patients are located in the United States, Germany, and the Republic of Korea. These hubs feature JCI-accredited facilities specializing in glioblastoma. They offer integrated care including radiosurgery and endoscopic tumor removal to maximize survival rates.
Bookimed Expert Insight: Seoul has become a top neuro-oncology destination due to its massive patient volumes. Asan Medical Center performs over 65,000 operations annually. Korea University Anam Hospital specializes in bloodless surgery. This high intensity allows doctors to master complex glioblastoma protocols quickly. This expertise levels the field with Western centers.
Top Republic of Korea hospitals follow a multimodal protocol. This starts with maximum surgical resection, followed by six weeks of chemo-radiotherapy and maintenance chemotherapy. JCI-accredited centres like Severance Hospital use 5-ALA fluorescence-guided surgery to identify and remove invasive tumour cells while sparing critical brain tissue.
Bookimed Expert Insight: Republic of Korea maintains some of the most densely digitalised health systems. Facilities like Seoul National University Hospital and its Bundang branch use integrated electronic patient records to coordinate multidisciplinary teams. This digital infrastructure helps specialists across neuro-oncology and radiation oncology track results in real-time. This level of coordination is vital for glioblastoma cases. It allows treatment sequencing to be adjusted immediately after high-volume surgeries.
Patient Consensus: Patients note that care in Republic of Korea is managed by multidisciplinary teams. They highlight the importance of asking for molecular profiling and clinical trial options after the initial surgery.
Glioblastoma treatments like immunotherapy and clinical trials are accessible at major tertiary hospitals in Seoul. Leading centres like Seoul National University Hospital (SNUH) and Severance Hospital host trials. These trials cover recurrent and newly diagnosed cases. Access depends on molecular markers and specific trial eligibility.
Bookimed Expert Insight: South Korea's glioblastoma care is highly concentrated in Seoul. SNUH alone serves 10,700 patients daily. Our data shows that 76 clinics operate in the region. Only large university hospitals like SNUH or Severance offer molecular profiling for trial eligibility. Australian patients should have their pathology and MRI files professionally translated before arrival. This helps speed up the screening process for limited trial spots.
Patient Consensus: Patients find that experimental treatments in South Korea are best accessed through larger academic hospitals. Practical barriers like trial eligibility mean preparing detailed medical records is essential for Australian patients. Having a local advocate also helps during the process.
South Korean glioblastoma treatment follows international protocols within JCI-accredited and Newsweek-ranked facilities. Specialised neuro-oncology teams use fluorescence-guided resection to remove 95% of brain tumours effectively. Patients receive radiotherapy and temozolomide chemotherapy at major centres including Asan Medical Center and Severance Hospital.
Bookimed Expert Insight: South Korea's glioblastoma care excels due to high patient volumes and digital infrastructure. Seoul National University Bundang Hospital serves 1.5 million patients yearly with a digital system. This high-volume environment helps specialists refine precision techniques like fluorescence-guided surgery. This expertise often leads to higher success rates in preserving healthy brain tissue.
Patient Consensus: Patients find the technology and the speed of treatment preparation impressive in South Korea. They value the clear communication about surgical risks and the organised post-operative care.
South Korean tertiary centres provide integrated neuro-rehabilitation and adjuvant therapy monitoring for glioblastoma patients. Care includes immediate post-operative MRI scans, daily physical therapy, and cognitive support. Facilities like Severance Hospital and Seoul National University Hospital coordinate these multi-disciplinary programs.
Bookimed Expert Insight: Korea University Anam Hospital uses minimal blood transfusion techniques. This approach often helps patients transition into active rehabilitation sooner. When choosing a clinic, patients should look for those with over 60,000 annual operations. This indicates the scale needed to support complex neuro-rehabilitation teams.
Patient Consensus: Patients in the Republic of Korea recommend confirming the specifics of neuro-rehabilitation before arrival. Many note the importance of a clear plan for handover to Australian GPs for ongoing steroid and seizure management.
Specialists in the Republic of Korea manage glioblastoma by integrating maximal safe resection with structured rehabilitation. They use fluorescence-guided imaging to preserve healthy brain tissue during surgery. This approach reduces neurological deficits. Multidisciplinary teams and digital health systems further help maintain patient safety and daily function.
Bookimed Expert Insight: South Korea's glioblastoma care stands out due to its high level of digitisation. Hospitals like Seoul National University Hospital (SNUH) and SNUBH have used digital patient records for over 20 years. This long-term data tracking allows multidisciplinary teams to adjust rehabilitation plans instantly. For patients, this means faster transitions from surgery to supportive therapy. This is critical for preserving speech and motor skills.
Neuro-oncology specialist teams in South Korea are structured within multidisciplinary academic hubs. These teams integrate neurosurgeons, medical oncologists, and radiation oncologists to manage complex brain cancers. Major Seoul-based centres use tools like Gamma Knife radiosurgery and fluorescence-guided surgery to treat glioblastoma.
Bookimed Expert Insight: While many countries have oncology units, South Korea's model is uniquely digitalised. Centres like Seoul National University Bundang Hospital use the BESTcare system to reduce medical errors. This digital approach supports surgical teams in handling high patient volumes. Some hospitals treat over 1,000,000 patients annually.